Logo

Data From Merck at ASCO 2020 to Showcase Significant Clinical ...

DARMSTADT, Germany and NEW YORK, April 30 /PRNewswire-AsiaNet/ -- - Not intended for US-, Canada- or UK-based media- ASCO Abstract #BAVENCIO® (avelumab): LBA1, 5061; Bintrafusp alfa (bifunctional fusion protein): 9558; Tepotinib (MET kinase inhibitor): 9556, 9575. - Late-breaking pres...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660